Formula Claims Draft Guidance: Health And Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Executive Summary
FTC considers Vemma settlement; UK firm's green tea claim fails; Axxess has new CEO; NeutraSci reaches Austria, Germany; and more news in brief.
You may also be interested in...
UK Turmeric Supplement Ads Outed For Using Claims 'On Hold' At EFSA
In separate rulings, ASA upholds complains that Healthspan and Cambridge Nutraceuticals made unapproved health claims for turmeric, as the firms did not provide sufficient supporting evidence and cannot rely on similar “on hold” claims on the ingredient under review by EFSA.
More Time For Formula Claim Guidance Comment: Health And Wellness Industry News Roundup
Mannatech founder Robbins leaves board; Nutra recalls GNC Women's supplement; historic UK center licenses Agragen omega-3 technology; and AngioSoma gains nutraceutical formulation patents
FTC Pyramid Scheme Investigation Brings Energy Drink Direct Seller To Standstill
FTC shuts down Vemma Nutrition on allegations of targeting college students and other young consumers in a pyramid scheme. The agency’s complaint in federal court follows consumer advocate Truth In Advertising’s two-year investigation of Vemma.